Savara Inc (SVRA) stock
SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.72+0.24 (+5.36%)
Close on Nov 18, 2026Market cap $969.77MP/E –Yield –
Savara operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Savara's operating cash flow for the twelve months ending Jun 30, 2026 was -$110.38M. For fiscal 2025 it was -$101.04M. The highest annual figure on record is -$4.78M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$101.04M | – |
| FY2024 | Dec 31, 2024 | -$89.09M | – |
| FY2023 | Dec 31, 2023 | -$51.06M | – |
| FY2022 | Dec 31, 2022 | -$34.55M | – |
| FY2021 | Dec 31, 2021 | -$40.08M | – |
| FY2020 | Dec 31, 2020 | -$39.84M | – |
| FY2019 | Dec 31, 2019 | -$45.12M | – |
| FY2018 | Dec 31, 2018 | -$39.28M | – |
| FY2017 | Dec 31, 2017 | -$28.23M | – |
| FY2016 | Dec 31, 2016 | -$8.37M | – |
| FY2015 | Dec 31, 2015 | -$4.78M | – |
| FY2014 | Dec 31, 2014 | -$24.65M | – |
| FY2013 | Dec 31, 2013 | -$17.79M | – |
| FY2012 | Dec 31, 2012 | -$13.92M | – |
| FY2011 | Dec 31, 2011 | -$13.47M | – |
| FY2010 | Dec 31, 2010 | -$8.34M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$29.75M | – |
| Q1 FY2026 | Mar 31, 2026 | -$33.05M | – |
| Q4 FY2025 | Dec 31, 2025 | -$25.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$22.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$26.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$27.19M | – |
| Q4 FY2024 | Dec 31, 2024 | -$23.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$22.67M | – |
| Q2 FY2024 | Jun 30, 2024 | -$22.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.64M | – |
| Q4 FY2023 | Dec 31, 2023 | -$15.60M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.27M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.03M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.65M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.16M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.32M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.43M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.93M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.19M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.60M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.30M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.71M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.75M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.08M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.95M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.41M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.91M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.86M | – |
| Q4 FY2018 | Dec 31, 2018 | -$10.49M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$10.35M | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.67M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.47M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.67M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.84M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.19M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.87M | – |
See a number that looks wrong?